Today: 9 November 2025
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Uranium Royalty Stock Soars on Nuclear Boom – UROY Hits New High, What’s Next?

Uranium Royalty Stock Soars on Nuclear Boom – UROY Hits New High, What’s Next?

UROY Stock Blasts Off Amid Uranium Market Revival Uranium Royalty Corp’s stock price has been on a tear, riding a wave of optimism in the nuclear energy sector. On October 15, UROY spiked intraday to about $4.87 per share, its highest level in a year marketbeat.com. It closed that session up over 11% at roughly $4.75 finviz.com – capping a stunning rally in recent months. Just a year ago UROY traded near $2.50; it has since doubled in value, now sitting ~85% higher than 12 months prior finviz.com. Over 116% of those gains have come in 2025 alone as the
16 October 2025
 ·  ·  ·  ·  · 
Adaptimmune (ADAP) Sees Wild Stock Surge Amid Cash Crunch – Biotech Turnaround or Last Gasp?

Adaptimmune (ADAP) Sees Wild Stock Surge Amid Cash Crunch – Biotech Turnaround or Last Gasp?

Stock Price Rollercoaster in 2025 Adaptimmune’s stock has been on a wild ride this year, with extreme price swings in recent weeks grabbing headlines. After languishing in penny-stock territory for months, ADAP suddenly caught fire in late September 2025. On September 19, shares opened at a mere $0.08 but skyrocketed 98% by day’s end to $0.16, then jumped another 30% after-hours to ~$0.20 ts2.tech. This stunning one-day move – without any company-specific catalyst – was accompanied by an enormous volume of 705+ million shares traded (versus ~60 million on an average day) ts2.tech. Market observers noted Adaptimmune as one of
16 October 2025
 ·  ·  ·  ·  ·  · 
Nancy Pelosi & Warren Buffett Are Both Betting on These 4 Stocks — What Do They Know?

Nancy Pelosi & Warren Buffett Are Both Betting on These 4 Stocks — What Do They Know?

Pelosi & Buffett’s $Billion Stock Overlap: Tech Titans and Financial Giants It’s not often that the “Oracle of Omaha” (Buffett) and a prominent Washington figure (Pelosi) end up betting on the same horses. Yet recent disclosures reveal four stocks common to both their portfolios benzinga.com. Amazon and Apple form the tech half of this overlap, while Visa and American Express form the finance half. In summary: these four shared stocks suggest that despite very different investing styles, Pelosi and Buffett are finding common ground in companies with dominant market positions and long-term growth stories. Their overlap spans two industries –
16 October 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
Silver Hits All-Time High Above $53 and Gold Tops $4,200 – Why Prices Are Soaring

Silver Hits All-Time High Above $53 and Gold Tops $4,200 – Why Prices Are Soaring

Precious Metals Surge to Historic Highs Gold and silver prices are shattering records as anxious investors rush into safe-haven assets. This week, spot gold blew past the $4,200/oz milestone for the first time ever reuters.com, extending a remarkable rally that’s seen it gain over 60% so far this year reuters.com. Gold has now notched five consecutive sessions of gains, peaking around $4,243 on Thursday morning (Oct. 16) reuters.com. Its sister metal silver has been on an even more spectacular tear: spot silver hit $53.60/oz on Tuesday – a new all-time high, finally surpassing the long-standing 1980 and 2011 peaks reuters.com.
16 October 2025
 ·  ·  ·  ·  ·  · 
Redwire (RDW) Shares Plummet on Shake-Up – Is a Takeoff Next?

Redwire (RDW) Shares Plummet on Shake-Up – Is a Takeoff Next?

Redwire (NASDAQ:RDW) closed about $9.40 on Oct 15, down ~1.5% on the day investing.com (after a 5.3% pop on Oct 14). The stock is volatile: it fell ~9.4% in one day and ~18.6% over a week after recent corporate news ts2.tech. Year-to-date, RDW is still down ~42% (despite a 12.8% one-year gain) ts2.tech. Major catalysts include a new Oct 14 partnership with Red Cat to pair Redwire’s Stalker drone with Red Cat’s Black Widow quadcopter businesswire.com, a Sept 25 contract to supply solar arrays for Axiom Space’s station module, and the Aug launch of SpaceMD, Redwire’s new pharmaceutical subsidiary (commercializing
15 October 2025
 ·  ·  ·  ·  ·  · 
HOVR Stock Rockets as Horizon Aircraft Lands Pratt & Whitney Engine Partnership

HOVR Stock Rockets as Horizon Aircraft Lands Pratt & Whitney Engine Partnership

Hybrid eVTOL Progress and Forecast New Horizon Aircraft is focused on certifying and producing its Cavorite X7, a 7-seat hybrid-electric VTOL aircraft. The company envisions a first flight-worthy prototype within ~18 months and full production by the late-2020s. CEO Brandon Robinson said the successful May 2025 test flight “was already an incredible year for the technical team,” and now they are pushing toward full-scale design completion verticalmag.com. Horizon notes it has the cash runway and partnerships (with Pratt & Whitney, government agencies, etc.) to achieve these goals sec.gov sec.gov. Financially, Horizon remains pre-revenue. Its Q1 FY2026 report (Aug–Oct 2025) did
15 October 2025
 ·  ·  ·  ·  · 
Rocket Lab (RKLB) Stock Blasts Off: Japan Launch Deals and Analyst Upgrades Fuel 700% Rally

Rocket Lab (RKLB) Stock Blasts Off: Japan Launch Deals and Analyst Upgrades Fuel 700% Rally

Stock Price and Market Momentum Rocket Lab shares have been on a tear. As of mid-day Oct. 15, 2025, RKLB was trading around $72 per share (up about 6.8% on the day) stockanalysis.com. The stock closed at about $68.03 on Oct. 14 (up ~4% that day) investing.com, extending a multi-week rally. Over the past year the shares are roughly 7× higher, and they regularly hit new highs – for example jumping ~7% to about $66 on Oct. 8 ts2.tech. Today’s price is well above the 50-, 100- and 200-day moving averages benzinga.com and is within striking distance of its 52-week
15 October 2025
 ·  ·  ·  ·  · 
Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge

Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge

Volatile Stock Performance in October 2025 Recursion’s stock showed wild swings in early October. On Oct 7, 2025 the shares fell about 5.4% to ~$5.23 amid a broad market slump nasdaq.com. The very next day (Oct 8) the stock rebounded sharply, jumping roughly 16% to ~$6.08 ts2.tech. This put RXRX near the middle of its 52-week trading range (about $3.97–$10.87) ts2.tech. Trading volume on these moves was heavy, with tens of millions of shares changing hands as investors positioned for upcoming company news. By Oct 14, RXRX was around $5.89 stocktitan.net. This volatility appears driven by renewed enthusiasm for Recursion’s
15 October 2025
 ·  ·  ·  ·  · 
Nokia Stock Surges on 5G Deals and Bullish Forecasts – What’s Next for NOK Investors?

Nokia Stock Surges on 5G Deals and Bullish Forecasts – What’s Next for NOK Investors?

Sources: Market quotes and technical data from Reuters reuters.com investing.com; Nokia financials and analyst data from MarketBeat marketbeat.com marketbeat.com; Nokia corporate news (deals, share issuance) from company releases and RTTNews nasdaq.com nasdaq.com; industry developments from Reuters and TelecomTV reuters.com reuters.com telecomtv.com ts2.tech; forecasts and expert comments from Reuters and investing analysis reuters.com reuters.com investing.com.
15 October 2025
 ·  ·  ·  ·  · 
NuScale’s Stock Skyrockets on 6GW SMR Deal – Is GE Vernova Missing Out?

NuScale’s Stock Skyrockets on 6GW SMR Deal – Is GE Vernova Missing Out?

Analysts Weigh In Analysts note that SMR’s recent rally reflects both real progress and speculative fervor. On one hand, NuScale’s NRC approvals and partnerships set it up as an industry leader finviz.com ts2.tech. In early October, NuScale shares even spiked +5% when Italy’s government moved to reintroduce nuclear power with “modular” reactors nasdaq.com nasdaq.com. On the other hand, NuScale still loses money (burning ~$95M cash per quarter as of mid-2025) and faces stiff competition nasdaq.com finviz.com. The Zacks report notes NuScale has underperformed peers recently (SMR +12.7% in 3 months vs. GE Vernova +17.6%, NanoNuclear +35%) finviz.com. It warns that
15 October 2025
 ·  ·  ·  · 
Canadian Solar (CSIQ) Stock Skyrockets: Analyst Upgrade & Battery Boom Ignite Rally

Canadian Solar (CSIQ) Stock Skyrockets: Analyst Upgrade & Battery Boom Ignite Rally

Stock Rally and Analyst Buzz Canadian Solar’s stock has surged sharply this week. On Oct 14 its share price hit a 52-week high of around $16.00 before closing at $15.72 marketbeat.com. This spike was driven by two main headlines: Goldman Sachs unexpectedly raised its CSIQ price target on Oct 9 (boosting investor confidence, even as Goldman still left a “sell” rating marketbeat.com), and news out of China about planned cuts to solar panel capacity (seen as reducing supply gluts). Indeed, Reuters reports that Chinese regulators may soon clamp down on excess PV manufacturing, which sent Chinese solar stocks soaring on
15 October 2025
 ·  ·  ·  ·  · 
Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Deal Details: Novo Licenses Omeros’s MASP-3 Inhibitor On Oct. 15, Novo Nordisk and Seattle-based Omeros announced a definitive asset purchase and license agreement. Under the terms, Novo gains exclusive global rights to zaltenibart (OMS906) for all indications. Omeros will receive $340 million up front and near-term milestones, plus up to $2.1 billion total with development and sales milestones and tiered royalties novonordisk.com. Reuters reported Novo would pay “up to $2.1 billion” for the experimental drug reuters.com. The deal is structured as a licensing asset purchase, not a full acquisition, and is expected to close in Q4 2025 marketscreener.com novonordisk.com. Novo’s Chief Scientific
15 October 2025
 ·  ·  ·  ·  ·  ·  · 
1 … 68 69 70 71 72 … 171
Go toTop